MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchCrypto SummaryFAQAbout
MYO - Myomo Inc
$0.49
-0.00(-0.88%)9:00:00 PM 1/30/2023
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace orthosis product used for supporting a patient's weak or paralyzed arm to enable and enhance functional activities of daily living, ADLs, in the home and community. Its products are designed to help restore function in individuals with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Summary:

  • Volatility is at a recent 2 week low. A recent low volatility of stock movement within a box range could trigger break through when activities pick up.
  • A moving average of short volume ratio is at a recent 2 week low. A lower short volume ratio could be a bullish signal.
Stock Statistics
MarketCap3.4M
PE Ratio
PEG Ratio15.0
P/B3.6
P/S (ttm)6.5
Earning Growth (QoQ)
Revenue Growth (QoQ)
Short %3%
Held by Institutions %41%
1 Day Vol Adjusted Return-0.1
1 Month Vol Adjusted Return1.4
3 Month Vol Adjusted Return-7.4
6 Month Vol Adjusted Return-10.1
20 Days SMA Price ZScore0.3
50 Days SMA Price ZScore-0.5
12 -26 Days PPO-4.9
1 Month Average Short Volume Ratio44.2
1 Day Volume Change ZScore0.1
1 Month Daily Vol7.2
Related Topics
Peers

Related Peers

Stock news

    01/30/2023MYO
    Myomo Appoints Yitzchak Jacobovitz to its Board of Directors

    BOSTON, January 30, 2023--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Yitzchak Jacobovitz as a Class II director effective January 27, 2023, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has six directors.

    01/17/2023MYO
    Myomo Announces Closing of $6.5 Million Upsized Public Offering

    BOSTON, January 17, 2023--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the closing of its previously announced "best efforts" public offering of 20,000,000 shares of common stock (or common stock equivalents in lieu thereof) at a public offering price of $0.325 per share for aggregate gross proceeds of approximately $6.5

    01/12/2023MYO
    Myomo Announces Pricing of $6.5 Million Upsized Public Offering

    BOSTON, January 12, 2023--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the pricing of its "best efforts" public offering of 20,000,000 shares of common stock (or common stock equivalents in lieu thereof) at a public offering price of $0.325 per share for aggregate gross proceeds of approximately $6.5 million, before dedu

    01/10/2023MYO
    Myomo Announces Initiative to Reduce Cash Burn

    BOSTON, January 10, 2023--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced a reduction in force for the purpose of improving operating efficiency in its direct billing channel and reduce its cash burn. The action today involved the elimination of approximately 12% of its workforce, impacting employees in its call center and

    12/7/2022MYO
    Myomo Provides Update on Progress to Obtain Medicare Part B Reimbursement for MyoPro

    BOSTON, December 07, 2022--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported progress and next steps in the process to obtain Medicare Part B reimbursement for the MyoPro® as a brace from the Centers for Medicare & Medicaid Services (CMS).

    12/5/2022MYO
    Ruling by German Social Court Supports MyoPro Reimbursement by Nation’s Statutory Health Insurance System

    BOSTON, December 05, 2022--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that in an appeal before the Berlin-Brandenburg Regional Social Court (L 9 KR 210/21), the court confirmed that the MyoPro powered whole-arm orthosis is an orthopedic aid that serves to directly compensate for disabilities. As a result of this ruling

    11/21/2022MYO
    10 Best Robotic Stocks Under $10

    In this article, we will be taking a look at the 10 best robotic stocks under $10. To skip our discussion on the robotics industry, you can go directly to the 5 Best Robotic Stocks Under $10. According to Statista, the size of the industrial robotics segment is expected to compound annually at an average […]

    11/10/2022MYO
    Myomo, Inc. (MYO) Reports Q3 Loss, Tops Revenue Estimates

    Myomo, Inc. (MYO) delivered earnings and revenue surprises of 14.89% and 4.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

    11/10/2022MYO
    Myomo Reports Third Quarter 2022 Financial Results Featuring Strong Authorizations and Orders and Record Backlog

    BOSTON, November 10, 2022--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three and nine months ended September 30, 2022.

    11/9/2022MYO
    NuVasive (NUVA) Surpasses Q3 Earnings Estimates

    NuVasive (NUVA) delivered earnings and revenue surprises of 1.89% and 0.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?